Top Story

Physician-related factors affect likelihood of breast preservation after second event

July 25, 2016

Mastectomy was more frequently used among patients with a second breast event than breast-conserving surgery in areas with high rates of radiotherapy for ductal carcinoma in situ, according to the results of a retrospective population-based analysis.

Because this analysis was restricted to patients eligible for breast conservation, this trend suggests physician-related factors may influence likelihood of breast preservation, according to the researchers.

In the Journals

Sorafenib associated with reduction in immune-suppressive phenotypes in patients with HCC

July 25, 2016
Sorafenib was associated with a reduction in immune-suppressive phenotypes in patients with hepatocellular carcinoma, according to recent findings published in JCI

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016
Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational…

Adjunctive systemic therapy: A reasonable option for patients with muscle-invasive bladder cancer

HemOnc Today, July 25, 2016
Donald L. Trump, MD, FACP
It is with considerable trepidation that I undertake the assignment to comment on — nay, adjudicate — the “point” and “counter”…
Cover Story

Immunotherapy, tumor profiling fill ‘gigantic knowledge gap’ in bladder cancer

HemOnc Today, July 25, 2016
The standard of care for patients with bladder cancer has remained largely unchanged for nearly 3 decades. The NCI estimates that 76,960 Americans will be diagnosed with…
More News Headlines »
CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
At Issue

VIDEO: Novel testing approaches better equip physicians to identify myeloma risks

July 16, 2016
More »
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting


The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today